AIP
ALNA

Ameritas Investment Partners’s Allena Pharmaceuticals ALNA Stock Holding History

Ameritas Investment Partners’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-460
Closed -$3K – 3145
2019
Q1 		$3K Hold
460
– – ﹤0.01% 2930
2018
Q4 		$3K Hold
460
– – ﹤0.01% 2927
2018
Q3 		$5K Hold
460
– – ﹤0.01% 2957
2018
Q2 		$6K Hold
460
– – ﹤0.01% 2930
2018
Q1 		$5K Hold
460
– – ﹤0.01% 2868
2017
Q4 		$5K Buy
+460
New +$5.67K ﹤0.01% 2882

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's ALNA Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Allena Pharmaceuticals (ALNA) in Q2 2019, closing a stake of 460 shares — an estimated $3K sold.

Ameritas Investment Partners first reported a position in ALNA in Q4 2017 and held it in 6 quarters. The position peaked at $6K in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q2 2019.

  • Ameritas Investment Partners reported no remaining Allena Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 460 Allena Pharmaceuticals shares in Q2 2019, an estimated $3K.
  • Ameritas Investment Partners first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • Ameritas Investment Partners's Allena Pharmaceuticals position peaked at $6K in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.